Syneos Health Partners with Equicare, Optimizing Data Capture and Integration to Accelerate Clinical Trial Research

MORRISVILLE, N.C. – February 8, 2023 – Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with Equicare to use proXimity™, an innovative cloud-based software platform that accelerates the transfer of clinical trial subject data from multiple electronic health records (EHR) to the sponsor’s electronic data capture systems (EDC).

Through the partnership, Syneos Health will use the proXimity platform to automate sponsor data transfers from EHRs to EDCs for clinical trials, helping to accelerate the performance of new therapies for patients. This collaboration support’s the Company’s commitment to listening and learning from sites and adapting to meet their most critical needs.

“At Syneos Health, we are committed to our customers, always. By partnering with Equicare to use proXimity, we are further addressing challenges sites and sponsors face regarding data capture, timelines and quality control,” said Michael Henning, President, Clinical Delivery, Syneos Health. “We’re confident this collaboration will help enhance the clinical trial experience for sites and sponsors by accelerating data entry and management to improve its accuracy and to help speed new therapies to patients.”

Typically, clinical trial subject data is transcribed manually by site coordinators or other staff from the EHR to the EDC, which is time-intensive and error-prone. proXimity automates this process and transfers the selected data from one system to another without the need for manual transcription, dramatically reducing the time needed to transfer data while helping to eliminate transcription errors.

While therapeutically agnostic, the proXimity software was first selected by NEXT Oncology – part of the Syneos Health Catalyst Site Program for phase I studies – as the exclusive tool to automate the transfer of clinical trial data from their EHR to EDC systems to speed the performance of new therapies in clinical trials. The platform now serves as a key tool for clinical trial data management, as well as assists sponsors in gaining access to their data to accelerate cancer research.

In a recently conducted proof of concept exercise where NEXT Oncology utilized proXimity to transfer data from the EHR to the Syneos Health managed EDC database, the data transfer was five times faster than manual entry and the data was transferred with 0% data entry errors, compared to a 3.5% error rate for manual data entry.

“We are using proXimity today for many of our studies and we are realizing the benefits as we are delivering the data to our sponsors more quickly with less errors,” said Dr. Anthony Tolcher, MD, Medical Oncologist and co-founder of NEXT Oncology. “In 2023, NEXT Oncology will utilize proXimity on all studies that utilize Medidata Rave as the EDC. We know this is the future to bring new therapies to cancer patients faster, and we are glad to have Syneos Health’s support with this strategy.”

About Syneos Health

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.

We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics.

Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.

Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.

Syneos Health Investor Relations Contact:

Ronnie Speight

Senior Vice President, Investor Relations

+1 919 745 2745

Investor.Relations@syneoshealth.com

Syneos Health Press/Media Contact:

Gary Gatyas

Executive Director, External Communications

+1 908 763 3428

gary.gatyas@syneoshealth.com

About Equicare Health

Equicare Health is the industry’s leading provider of comprehensive care coordination solutions for oncology. EQUICARE CS™ (ECS) is a multi-facility web-based software tool that facilitates patient engagement including patient reported outcomes, patient navigation, survivorship care and a several other clinical tools. proXimity is a tool set designed to automate data transfer between EMRs and EDCs in support of sponsored clinical trials. For more information, visit please visit www.dataproXimity.com.

Equicare Health Media Contact:

Marnie Sanders VP, proXimity

Equicare Health Inc.

+1.303.506.9050

marnie.sanders@equicarehealth.com

NEXT Oncology Selects proXimity™ to Automate Data Transfer for Clinical Trials

System will accelerate performance evaluation of new drugs in early phase research for cancer patients

(SAN ANTONIO) October 17, 2022 –– NEXT Oncology has selected proXimity™ as the exclusive tool to automate the transfer of clinical trial data from their electronic medical record (EMR) to the electronic data capture (EDC) systems used by sponsor organizations doing clinical trials with NEXT Oncology. This will accelerate the performance of new therapies in clinical trials for patients with cancer.

proXimity™ is an innovative cloud-based software platform that accelerates the transfer of clinical trial subject data from multiple electronic medical records (EMR) to the sponsor’s electronic data capture systems (EDC). Typically, this data is transcribed manually by data management employees from the EMR to the EDC, which is time-intensive and error-prone. proXimity™ automates this process and transfers the data from one system to another without the need for manual transcription, dramatically reducing the time needed to transfer data while eliminating transcription errors.

“NEXT Oncology is dedicated to the advancement of new anti-cancer therapies through early phase clinical trials with the goal of providing innovative developments in cancer research and treatment,” said Anthony Tolcher, MD, founder of NEXT and renowned cancer researcher. “This is the future of data transfer, and we are embracing it! We are using proXimity™ today for many of our studies and we are realizing the benefits as we are delivering the data more quickly with less errors to our sponsors. This tool is necessary to speed up clinical trial data management as well as assist our sponsors in gaining access to their data so we can accelerate cancer research. We want to bring new therapies to cancer patients faster.”

In a recently conducted pilot study using proXimity™ to transfer data from the EMR to the EDC, the data transfer using proXimity™ was 5 times faster than manual entry and the data was transferred error free compared to 3.5 % manual entry.

In 2023, NEXT Oncology will utilize proXimity™ on all studies that utilize Medidata Rave as the EDC.

About NEXT Oncology

NEXT Oncology is dedicated to the development of new anticancer agents for patients whose current cancer therapy is no longer working to benefit them and are looking for their next option. NEXT is partnered with Texas Oncology, the largest private oncology practice in the United States with more than 400 referring oncologists and US Oncology, a network of independent, community-based oncologists in the U.S. This formidable size and reach provide NEXT unprecedented opportunities to transform what has come to be expected from clinical trials of new agents.

About Equicare Health

Equicare Health is the industry’s leading provider of comprehensive care coordination solutions for oncology. EQUICARE CS™ (ECS) is a multi-facility web-based software tool that facilitates patient engagement including patient reported outcomes, patient navigation, survivorship care and a several other clinical tools. Proximity is a tool set designed to automate data transfer between EMRs and EDCs in support of sponsored clinical trials.

Texas Oncology selects proXimity™ to automate data transfer for clinical trials

VANCOUVER, BC, May 31, 2022 /CNW/ – Texas Oncology has selected proXimity™ as the primary tool to automate the transfer of clinical trial data from the oncology EMR to the electronic data capture (EDC) systems used by biotech, pharmaceutical, and contract research organizations providing clinical trials with Texas Oncology.

proXimity is an innovative cloud-based software platform that accelerates the transfer of clinical trial subject data from multiple electronic medical records (EMR) to the sponsor’s electronic data capture systems (EDC). Typically, this data is transcribed manually by data management employees from the EMR to the EDC, which is time-intensive and error-prone. proXimity automates this process and transfers the data from one system to another without the need for manual transcription, dramatically reducing the time needed to transfer data while eliminating transcription errors.

Texas Oncology is a leader in cancer research and clinical trials with more than 1500 patients enrolled annually and, on average, 150+ open national trials. In a recent pilot study conducted using proXimity to transfer data from the EMR to the EDC, the data transfer using proXimity™ was 4.5 times faster than manual entry and the data was transferred error free compared to manual entry.

“We look forward to leveraging proXimity in our ongoing program to combine clinical and operational excellence in the performance of clinical trials. With our large network and mass of data, proXimity holds the potential to not only accelerate data entry and management, but also to significantly improve its accuracy. This is a big win for cancer research and cancer patients in Texas,” said Scott Paulson, M.D. medical oncologist and director of clinical research at Texas Oncology.

About Texas Oncology

Texas Oncology is an independent private practice with more than 500 physicians and 210 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, Texas Urology Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 100 FDA-approved therapies. For more information, visit www.TexasOncology.com.

About Equicare Health

Equicare Health is the industry’s leading provider of comprehensive care coordination solutions for oncology. EQUICARE CS™ (ECS) is a multi-facility web-based software tool that facilitates patient engagement including patient reported outcomes, patient navigation, survivorship care and a several other clinical tools. Proximity is a tool set designed to automate data transfer between EMRs and EDCs in support of sponsored clinical trials. For more information, visit www.dataproXimity.com.

Len Grenier, (604) 398-2325, len.grenier@equicarehealth.com

Equicare Health Releases Video conferencing, giving healthcare providers the ability to Connect securely with their and patients and colleagues.

Vancouver, CANADA – April -, 2020. Equicare Health Inc., the leading provider in oncology care coordination and patient navigation solutions, introduces EQUICARE CONNECT, a secure, cloud-based video conferencing platform that allows clinicians and support staff to communicate with healthcare providers, patients and their families.

“We recognize the importance of staying connected with healthcare professionals and patients during this challenging time,” says Len Grenier, CEO. “Oncology patients already have immuno-suppressed systems so the ability to screen and triage patients without coming into the clinic through EQUICARE CONNECT reduces patient and staff exposure to potential infectious diseases.”

In addition, there are no downloads required which makes patient access quick and simple. EQUICARE CONNECT is Technology neutral, HIPAA compliant and can be used by the entire clinical team at a fraction of the cost of other systems.  Video Conferencing is imperative during the COVID-19 crisis, and it will remain a valuable tool long after the virus is under control.

For more information, please visit www.equicarehealth.com or email us at info@equicarehealth.com.

About Equicare Health

Equicare Health is the industry’s leading provider of comprehensive care coordination solutions. EQUICARE CS™ (ECS) is a multi-facility web-based software tool that facilitates patient engagement including patient reported outcomes, patient navigation, survivorship care and a several other clinical tools, i.e. MDT, Clinical trials, a suite of educational material, etc. In additional to the clinical toolset, Equicare offers an administrative suite of worklists and reports for managing adherence to accreditation standards including Meaningful Use, Commission on Cancer (CoC), NAPBC, QOPI, OCM, etc. ECS enables cancer centers to influence clinical outcomes for patients, optimize revenue streams, and increase operational efficiency. 

For more information, please contact:

Margaret Nash

Vice President, Global Sales & Marketing

Margaret.nash@equicarehealth.com

980.939.2230

Equicare Health releases latest version of their product, Equicare CS 4.10

Vancouver, CANADA – April 9, 2019 – Equicare Health, the leading provider of oncology care coordination and patient navigation solutions, officially released the latest version of their product, Equicare CS (ECS) 4.10.

“ECS 4.10 adds a number of new features that make it easier to collect and monitor Patient Reported Outcomes as part of standard clinical practice. The release also includes patient navigation workflow improvements, and GDPR support for our customers in the European Union,” says Malcolm Wright, VP of Product Management at Equicare Health.

The new release includes a feature to automatically assign questionnaires to patients based on compliance goals and clinical need.  We’ve also added a new kiosk that allows patients to complete forms and questionnaires using a tablet in the waiting room.

For more information on our new release or to request an upgrade, please contact Equicare

About Equicare Health

Equicare Health is the industry’s leading provider of comprehensive care coordination solutions. Equicare’s flagship solution EQUICARE CS™ (ECS) is a Multi-facility web-based software tool that facilitates patient engagement including patient reported outcomes, patient navigation, survivorship care and a number of other clinical tools, i.e. MDT, Clinical trials, a suite of educational material, etc.. In additional to the clinical toolset, Equicare offers an administrative suite of worklists and reports for managing adherence to accreditation standards including Meaningful Use, Commission on Cancer (CoC), NAPBC, QOPI, OCM, etc… ECS enables cancer centers to influence clinical outcomes for patients, optimize revenue streams, and increase operational efficiency. www.equicarehealth.com

For more information, please contact:

Margaret Nash
Global Vice President – Sales and Marketing
margaret.nash@equicarehealth.com
980-939-2230

Equicare Health releases latest version of their product, Equicare CS 4.8

Vancouver, CANADA – April 4, 2018 – Equicare Health, the leading provider of oncology care coordination and patient navigation solutions, officially releases the latest version of their product, Equicare CS (ECS) 4.8.

“Version 4.8 has been certified for MIPS ACI 2015 Edition and supports integration with Elekta’s Mosaiq 2.6 and Varian’s ARIA 15.5.  We’ve also introduced new tools for managing Tumor Board meetings, as well as a complete refresh of our Oncology Patient Education Library,” says Malcolm Wright, VP of Product Management at Equicare Health.

ECS 4.8 includes a new Case Finding feature, as well as charting improvements that make it easier for providers to organize patient assessment and encounter notes.

For more information on the new release, please contact Equicare to learn more.

About Equicare Health
Equicare Health is the industry’s leading provider of comprehensive care coordination solutions. Equicare’s flagship solution EQUICARE CS™ (ECS) is a Multi-facility web-based software tool that facilitates patient engagement including patient reported outcomes, patient navigation, survivorship care and a number of other clinical tools, i.e. MDT, Clinical trials, a suite of educational material, etc.. In additional to the clinical toolset, Equicare offers an administrative suite of worklists and reports for managing adherence to accreditation standards including Meaningful Use, Commission on Cancer (CoC), NAPBC, QOPI, OCM, etc… ECS enables cancer centers to influence clinical outcomes for patients, optimize revenue streams, and increase operational efficiency. www.equicarehealth.com

For more information, please contact:
Celina Lam
Marketing Communications Specialist
celina.alisa.lam@gmail.com
604-398-2956

Elekta and Equicare Health establish reseller agreement to enhance cancer patient engagement, care and management

Agreement supports improved clinical outcomes through survivorship care plans that enable earlier detection and intervention for treatment-related side effects and disease recurrence

ATLANTA, February 1, 2018 – Elekta (EKTA-B.ST) today announced that it is has entered into a reseller agreement with Equicare Health, a leader in developing chronic care models for cancer survivorship that improve patient outcomes and maximize cancer centers’ operational efficiencies. Under the terms of the agreement, Elekta will now offer EQUICARE CS™ and Equicare’s Active Patient Portal to current and future users of Elekta’s MOSAIQ® Oncology Electronic Health Record (EHR). EQUICARE CS and the Active Patient Portal complement MOSAIQ, facilitating communication between patients and clinicians with no geographic restrictions. Patients can receive updates on their care plans, provide feedback and patient reported outcomes through the platform. Clinical information is integrated into MOSAIQ directly from EQUICARE CS.

MOSAIQ is a leading open system that also provides actionable analytics to support improvements in the quality and cost of care. MOSAIQ is designed for interoperability with a broad array of digital health solutions to drive the open exchange of information and promote an all-inclusive workflow empowering patient care providers.

“The evolving needs of our customer base require us to think beyond what individual software solutions can offer,” said Margaret Nash, Global VP of Sales for Equicare. “Equicare’s products provide a unique and much-needed solution for efficiently managing and communicating with cancer patients. Cancer centers using our digital solutions in the context of MOSAIQ’s comprehensive EHR will now have a powerful system for connecting these patient interactions to the treatment management process. This allows an entire care team to document and review a patient’s complete history, starting as early as the patient’s first screening visit and extending well beyond the last day of treatment, improving patient outcomes while optimizing the use of oncology resources.”

EQUICARE CS is used to coordinate cancer care, manage patient navigation and facilitate the creation of survivorship plans based on recommendations from the Institute of Medicine and the American Society of Clinical Oncology. Patient navigation and survivorship plans are both required for cancer care centers to receive accreditation from the Commission on Cancer. The Active Patient Portal allows patients undergoing cancer treatment to access the latest medical information, stay on top of scheduled appointments, lab results and medical notes, as well as send/receive secure messages with care team members. It also provides insight into patient populations by aggregating valuable data collected in questionnaires that can help measure long-term clinical outcomes for entire patient populations.

“Elekta is committed to ensuring that our digital solutions interface seamlessly with systems and applications across the evolving healthcare ecosystem that share our goal of advancing patient care,” said Andrew Wilson, Vice President of Global Marketing for Software Solutions at Elekta. “We believe that the combination of MOSAIQ and Equicare’s offerings gives users unparalleled resources for effectively managing the entire oncology care continuum and improving survival and quality of life for cancer survivors.”

 

For further information, please contact:

Gert van Santen, Group Vice President Corporate Communications, Elekta AB

Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com

Time zone: CET: Central European Time

Raven Canzeri, Global Public Relations Manager
Tel: +1 770 670 2524, e-mail: raven.canzeri@elekta.com
Time zone: ET: Eastern Time

 

About Elekta

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com.

About Equicare Health

Equicare Health is the industry’s leading provider of comprehensive care coordination and patient navigation solutions. Equicare’s flagship solution EQUICARE CS™ (ECS) is a multi-facility web-based software tool, which enables cancer centers to influence clinical outcomes for patients, optimize revenue streams, and increase operational efficiency. ECS facilities patient engagement through patient reported outcomes, patient navigation, and survivorship care. The software provides other clinical tools (including MDT, Clinical trials, education material, and patient engagement) as well as an administrative suite of worklists and reports for managing adherence to accreditation standards (including Meaningful Use, Commission on Cancer (CoC), NAPBC, QUOPI, OCM). ECS enables cancer centers to influence clinical outcomes for patients, optimize revenue streams, and increase operational efficiency. To learn more, please visit www.equicarehealth.com.

 

Equicare Health releases latest product, Equicare CS (ECS) 4.7

Vancouver, CANADA –December 1, 2017 – Equicare Health, the leading provider of oncology care coordination and patient navigation solutions, releases latest version of their product, Equicare CS (ECS) 4.7.

“We’re excited to be releasing ECS version 4.7 to our customers. With this version we’ve completely re-designed the patient portal to provide beautiful, clean screens and simple workflows,” says Malcolm Wright, VP of Product Management at Equicare Health.

ECS 4.7 supports mobile, so patients can access the portal from their mobile phone, tablet, or desktop. The system also supports multiple languages, so patients can benefit from ECS whether or not they speak English. Version 4.7 supports English and Spanish, and additional languages will be added with each release.

ECS 4.7 is now available. For more information on the new release, please contact Equicare to learn more.

About Equicare Health

Equicare Health is the industry’s leading provider of comprehensive care coordination and patient navigation solutions. Equicare’s flagship solution EQUICARE CS™ (ECS) is a multi-facility web-based software tool, which enables cancer centers to influence clinical outcomes for patients, optimize revenue streams, and increase operational efficiency. ECS facilities patient engagement through patient reported outcomes, patient navigation, and survivorship care. The software provides other clinical tools (including MDT, Clinical trials, education material, and patient engagement) as well as an administrative suite of worklists and reports for managing adherence to accreditation standards (including Meaningful Use, Commission on Cancer (CoC), NAPBC, QUOPI, OCM). ECS enables cancer centers to influence clinical outcomes for patients, optimize revenue streams, and increase operational efficiency. To learn more, please visit www.equicarehealth.com.

For more information, please contact:
Celina Lam
Marketing Communications Specialist
celina.alisa.lam@gmail.com
604-398-2956

Equicare Health introduces Equicare CS (ECS) 4.7 at the ASTRO 2017 Annual Meeting

Vancouver, CANADA – September 21, 2017 – Equicare Health, the leading provider of oncology care coordination and patient navigation solutions, will introduce the  latest release of their product, ECS 4.7, at the ASTRO 2017 Annual Meeting in San Diego.

“Every year, ASTRO showcases the best of oncology technology and we are excited to show off our latest release – ECS 4.7 – at this year’s meeting. Version 4.7 introduces some significant additions to our software, including a newly designed patient portal that optimizes the user’s experience,” says Malcolm Wright, VP of Product Management at Equicare Health.

ECS 4.7 follows a responsive design, where patients can use the portal from any device including their mobile phone, tablet, or desktop. The system also supports multiple languages, so patients can benefit from ECS whether or not they speak English. Version 4.7 supports English and Spanish, and additional languages will be added with each release.

ECS 4.7 will officially be available to the public in October.

ASTRO attendees and registrants are encouraged to visit Equicare during exhibit hours; September 24 to 26 from 10:00 a.m. to 5:00 p.m. in Booth #2455 to learn more about Equicare’s products and services.

About Equicare Health

Equicare Health is the industry’s leading provider of comprehensive care coordination and patient navigation solutions. Equicare’s flagship solution EQUICARE CS™ (ECS) is a multi-facility web-based software tool, which enables cancer centers to influence clinical outcomes for patients, optimize revenue streams, and increase operational efficiency. ECS facilities patient engagement through patient reported outcomes, patient navigation, and survivorship care. The software provides other clinical tools (including MDT, Clinical trials, education material, and patient engagement) as well as an administrative suite of worklists and reports for managing adherence to accreditation standards (including Meaningful Use, Commission on Cancer (CoC), NAPBC, QUOPI, OCM). ECS enables cancer centers to influence clinical outcomes for patients, optimize revenue streams, and increase operational efficiency. To learn more, please visit www.equicarehealth.com.

For more information, please contact:

Celina Lam
Marketing Communications Specialist
celina.alisa.lam@gmail.com
604-398-2956

 

Equicare Health ranks 217th on the 2017 PROFIT 500

Vancouver, CANADA – September 14, 2017 – Equicare Health, the leading provider of oncology care coordination and patient navigation solutions, ranks 217th on the 29th annual PROFIT 500 as one of Canada’s Fastest-Growing Companies.

“It is never easy to earn a spot on the PROFIT 500, but this year’s applicant pool was the most competitive yet,” says Deborah Aarts, PROFIT 500 Program Manager. “This year’s winners demonstrate the resilience, innovation and sheer management smarts it takes to build a thriving business today. Canada—and the world—needs more entrepreneurial success stories like these.”

PROFIT 500 is an annual listing that ranks Canadian businesses by their five-year revenue growth. This year, PROFIT 500 companies will be published in the October issue of Maclean’s magazine and CanadianBusiness.com

“Equicare is honoured to be part of this year’s PROFIT 500, being recognized alongside many innovative companies nationwide,” says Len Grenier, CEO at Equicare Health. “Our continued success reflects the hard work and commitment of our team. We will continue to build on our successes and deliver leading oncology care coordination solutions to cancer patients and oncology care providers.”

PROFIT 500 follows Equicare’s recent recognition as one of Business in Vancouver’s (BIV) Fastest Growing Companies earlier this month.

About Equicare Health
Equicare Health is the industry’s leading provider of comprehensive care coordination solutions. Equicare’s flagship solution EQUICARE CS™ (ECS) is a Multi-facility web-based software tool that facilitates patient engagement including patient reported outcomes, patient navigation, survivorship care and a number of other clinical tools, i.e. MDT, Clinical trials, a suite of educational material, etc.. In additional to the clinical toolset, Equicare also offers an administrative suite of worklists and reports for managing adherence to accreditation standards including Meaningful Use, Commission on Cancer (CoC), NAPBC, QOPI, OCM, etc… ECS enables cancer centers to influence clinical outcomes for patients, optimize revenue streams, and increase operational efficiency. www.equicarehealth.com

About the PROFIT 500
For 29 years, the PROFIT 500 has been Canada’s most respectable  and influential ranking of entrepreneurial achievement. Developed by PROFIT and now published in Maclean’s magazine and at CanadianBusiness.com, the PROFIT 500 ranks Canadian companies on five-year revenue growth. For more information on the ranking visit PROFIT500.com or CanadianBusiness.com.

About Canadian Business
Founded in 1928, Canadian Business is the longest-serving and most-trusted business publication in the country. It is the country’s premier media brand for executives and senior business leaders. It fuels the success of Canada’s business elite with a focus on the things that matter most: leadership, innovation, business strategy and management tactics. Learn more at CanadianBusiness.com.

For more information, please contact:
Celina Lam
Marketing Communications Specialist
celina.lam@equicarehealth.com
604-398-2956

Top